Simponi Aria regulatory update

Johnson and Johnson’s Janssen Biotech Inc. unit submitted a pair of sBLAs to FDA for Simponi Aria golimumab to treat active psoriatic arthritis and active ankylosing spondylitis, respectively. Simponi...